Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
264.34
-0.78 (-0.29%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,528,233
Open
265.49
Bid (Size)
263.20 (300)
Ask (Size)
265.20 (800)
Prev. Close
265.12
Today's Range
262.59 - 266.00
52wk Range
190.75 - 269.39
Shares Outstanding
N/A
Dividend Yield
2.62%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
↗
Today 17:22 EDT
AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories.
Via
The Motley Fool
Topics
Intellectual Property
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?
↗
September 24, 2026
Novo Nordisk trades at a steep discount on earnings and sales, while AbbVie grapples with patent cliffs and pricing pressure, but profitability tells a different story.
Via
The Motley Fool
Topics
Intellectual Property
Performance
YTD
+15.3%
+15.3%
1 Month
-0.5%
-0.5%
3 Month
+8.7%
+8.7%
6 Month
+25.2%
+25.2%
1 Year
+20.2%
+20.2%
More News
Read More
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
↗
September 24, 2026
Via
The Motley Fool
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade
↗
September 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?
↗
September 22, 2026
Via
The Motley Fool
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
Via
StockStory
Topics
Artificial Intelligence
AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now?
↗
September 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 18, 2026
Via
The Motley Fool
Topics
Intellectual Property
Where Will Novo Nordisk Be in 5 Years as the GLP-1 Market Gets More Crowded?
↗
September 16, 2026
Via
The Motley Fool
Topics
Economy
Is AbbVie the Best Dividend King to Buy in September?
↗
September 16, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 Dividend Stocks That Are No-Brainer Buys Right Now, Starting With This Healthcare Giant
↗
September 15, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline
↗
September 15, 2026
Via
MarketBeat
Topics
ETFs
Billionaire Ken Griffin Just Loaded Up on This Dividend King, and Wall Street Still Sees Upside
↗
September 14, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 14, 2026
Via
The Motley Fool
Why Did Billionaire Israel "Izzy" Englander More Than Double His Stake in AbbVie Stock and Start a Position in SpaceX Stock?
↗
September 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 10, 2026
Via
The Motley Fool
Topics
Intellectual Property
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
↗
September 09, 2026
Via
Benzinga
AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo Conference
↗
September 09, 2026
Via
MarketBeat
2 Dividend Stocks Built to Hold Up When Markets Don't
↗
September 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Billionaire Israel Englander Is Doubling Down on These 2 Outstanding Dividend Stocks. Should You?
↗
September 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
If I Were in My 20s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever
↗
September 08, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now
↗
September 08, 2026
Via
The Motley Fool
Topics
Intellectual Property
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
↗
September 06, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Bonds
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King)
↗
September 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 264.34
When was AbbVie last traded?
The last trade of AbbVie was at 09/25/26 04:10 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.